SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-000321
Filing Date
2024-01-03
Accepted
2024-01-03 18:37:24
Documents
3
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704325032.html 4  
1 FORM 4 wk-form4_1704325032.xml 4 3188
2 EX-24 powerofattorney_johnsonx.htm EX-24 3783
3 powerofattorney_johnsonx001.jpg GRAPHIC 200901
  Complete submission text file 0001628280-24-000321.txt   285213
Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 24508887

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)